Gelonghui November 8th | huaren pharmaceutical (300110.SZ) announced that the company recently received a notice from Hongta innovation regarding the implementation of the shareholding reduction plan for huaren pharmaceutical. The above-mentioned shareholding reduction plan by Hongta innovation has been completed. Hongta innovation has cumulatively reduced its holding of the company's shares by 11,800,000 shares during this shareholding reduction plan period, with a reduction rate of 1.00%.
华仁药业(300110.SZ)：红塔创新完成减持1.00%股份
huaren pharmaceutical (300110.SZ): Red Tower Innovation completes the shareholding of 1.00% of the shares
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated